• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Venator Materials PLC

    10/30/23 3:05:10 PM ET
    $VNTR
    Major Chemicals
    Industrials
    Get the next $VNTR alert in real time by email
    SC 13D 1 venator_13d.htm

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934
    (Amendment No. ________)*

         
      Venator Materials PLC  
      (Name of Issuer)  
         
      Ordinary Shares, $0.001 par value per share  
      (Title of Class of Securities)  
         
      G9329Z100  
      (CUSIP Number)  
         
         
     

    Erik A. Vayntrub

    Capital World Investors

    333 South Hope Street, 55th Floor

    Los Angeles, CA 90071

    (213) 486-9108

     
      (Name, Address and Telephone Number of Person Authorized to  
      Receive Notices and Communications)  
         
      October 12, 2023  
      (Date of Event which Requires Filing of this Statement)  
         

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ _ ]

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. G9329Z100

     

     

    13D

     

    Page 2 of 6

     

    1 NAMES OF REPORTING PERSONS
       
      Capital World Investors
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    
        (a) [ _ ]
        (b) [ x ]
           
    3 SEC USE ONLY    
           
           
    4 SOURCE OF FUNDS    
           
      OO    
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED    
      PURSUANT TO ITEMS 2(d) OR 2(e)   [ _ ]
           
           
    6 CITIZENSHIP OR PLACE OF ORGANIZATION    
           

    Delaware

        7 SOLE VOTING POWER

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       
      19,425,906,043
    8 SHARED VOTING POWER
       
      0
    9 SOLE DISPOSITIVE POWER
       
      19,425,906,043
    10 SHARED DISPOSITIVE POWER
       

    0

    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      19,425,906,043    
    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
          [ _ ]
           
           
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)    
           
      18.0%(1)    
    14 TYPE OF REPORTING PERSON    
           
      IA    

     

    The calculation of the percentage of the class beneficially owned by the reporting person is based on 108,050,720,920 Ordinary Shares that were expected to be issued and outstanding as of October 13, 2023, as reported by the Issuer in its Form 6-K, filed with the SEC on October 13, 2023.

     

     

     

     

    CUSIP No. G9329Z100

     

     

    13D

     

    Page 3 of 6

     

     

     

    Item 1. Security and Issuer.    
         
     

    This statement on Schedule 13D (this “Schedule 13D”) relates to Ordinary Shares, $0.001 par value per share (the “Ordinary Shares”), of Venator Materials PLC, an England and Wales corporation (the “Issuer”), the principal executive offices of which are located at Titanium House, Hanzard Drive, Wynyard Park, Stockton-On-Tees, TS22 5FD, United Kingdom.

     

    Item 2. Identity and Background.    
         
    (a)

    This Schedule 13D is filed on behalf of Capital World Investors (“CWI” or the “Reporting Person”), a division of Capital Research and Management Company (“CRMC”), a Delaware corporation, as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the “investment management entities”). CWI’s divisions of each of the investment management entities collectively provide investment management services under the name “Capital World Investors.”

     

    Set forth in the attached Schedule A and incorporated herein by reference is a listing of the information, including name, principal place of business, and citizenship, concerning each investment committee member of the Reporting Person (collectively, the “Covered Persons”). Any disclosures herein with respect to persons other than the Reporting Person are made on information and belief after making inquiry to the appropriate party.

           
    (b) The business address of CWI is 333 South Hope Street, 55th Floor, Los Angeles, CA 90071. The business address of each Covered Person is set forth on Schedule A and is incorporated herein by reference.
           
    (c) The principal business of CWI is providing investment management services for the American Funds® family of mutual funds, as well as for other investment advisory clients through separate accounts, trusts and funds worldwide.
           
    (d) Neither the Reporting Person, nor, to the best of its knowledge, any Covered Person, during the last five years, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
           
    (e) Neither the Reporting Person, nor, to the best of its knowledge, any Covered Person, during the last five years, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
           
    (f) See Item 2(a) above. The citizenship of each Covered Person is set forth on Schedule A and is incorporated herein by reference.
           
    Item 3. Source and Amount of Funds or Other Consideration.  
       
     

    On January 17, 2023, the Issuer and certain of its subsidiaries (collectively, the “Debtors”) filed voluntary petitions in the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”) seeking relief under chapter 11 of title 11 of the U.S. Bankruptcy Code. On July 25, 2023, the Bankruptcy Court entered an order (the “Confirmation Order”) confirming the Joint Prepackaged Plan of Reorganization of Venator Materials PLC and its Debtor Affiliates (the “Plan”). On October 12, 2023 (the “Effective Date”), the Plan became effective in accordance with its terms and the Debtors emerged from chapter 11.

     

    Pursuant to the Plan and the Confirmation Order, the Issuer issued certain Ordinary Shares to investment advisory clients of CWI (the “CWI Clients”) (i) in exchange for debt held by the CWI Clients prior to the filing of the Debtors’ voluntary bankruptcy petition which was cancelled, (ii) in respect of premiums in consideration for backstop commitments made with respect to the Debtors’ exit facility, and (iii) in conversion of DIP loans held by the CWI Clients.

     

     

     

     

     

     

    CUSIP No. G9329Z100

     

     

    13D

     

    Page 4 of 6

     

     

         
    Item 4. Purpose of Transaction.    
         
     

    The information set forth in Item 3 is incorporated herein by reference.

     

    Pursuant to the terms of the Plan, the Reporting Person received Ordinary Shares as reported in Item 3. These shares were acquired for investment purposes.

     

    On the Effective Date, the Issuer entered into a Shareholders’ Agreement (the “Shareholders’ Agreement”) with the CWI Clients and other shareholders of the Issuer (the “Shareholders”). The Shareholders’ Agreement provides that the board of the Issuer (the “Board”) shall comprise up to seven independent directors, with the initial directors set out in the Shareholders’ Agreement. The Shareholders’ Agreement provides that if a vacancy on the Board arises, the new directors shall be appointed by the Shareholders, with each Shareholder holding fifteen percent (15%) of the voting shares in issue entitled to appoint and remove one director for every fifteen percent (15%) of voting shares in issue held. The Shareholders’ Agreement provides that the chairperson of the Board is to be elected by a majority of the Board. Certain matters are reserved to the decision of holders of (i) seventy five percent (75%) or more of voting shares; (ii) sixty percent (60%) or more of voting shares; and (iii) fifty percent (50%) or more of voting shares. The Shareholders’ Agreement also provides for tag-along rights for Shareholders upon the transfer by a Shareholder and / or their affiliates which would result in the prospective purchaser owning or controlling more than fifty percent (50%) of the voting shares in issue; drag-along rights upon the transfer of shares by a Shareholder or group of Shareholders who hold fifty percent (50%) or more of the voting shares in issue which would result in the prospective purchaser owning or controlling more than fifty percent (50%) of the voting shares in issue; rights of first offer with respect to the transfer by a Shareholder (subject to certain customary exceptions) of five percent (5%) or more of the outstanding shares of the voting shares; and pre-emptive rights to the Shareholders (on a pro rata basis) upon issuance of new securities by the Issuer (subject to certain customary exceptions). Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that the Reporting Person or any of its affiliates (i) constitute a “group” for purposes of Section 13(d) or 13(g) of the Exchange Act with the other Shareholders and the Reporting Person expressly disclaims membership in any such group, or (ii) are the beneficial owners of any Ordinary Shares beneficially owned by the other Shareholders for purposes of Section 13(d) of the Exchange Act or for any other purpose. The foregoing description of the Shareholders’ Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Shareholders’ Agreement, which is filed hereto as Exhibit 99.1 and is incorporated by reference herein.

    The Reporting Person intends to evaluate on an ongoing basis its investment in the Issuer and its options with respect to such investment. Depending on market conditions, an evaluation of the business and the prospects of the Issuer and other factors, the Reporting Person may, in its sole discretion, purchase additional Ordinary Shares, or other securities convertible into or exchangeable for Ordinary Shares, and/or other equity, debt, notes, instruments or other securities of the Issuer, dispose of Ordinary Shares or such other securities from time to time in the open market, in privately negotiated transactions or otherwise, and/or otherwise change its intention with respect to any and all matters referred to in this Item 4.

    Except as set forth herein, the Reporting Person does not have, as of the date of this filing any plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Person reserves the right to adopt such plans or proposals in the future, subject to applicable regulatory requirements, if any.

           
    Item 5. Interest in Securities of the Issuer.    
           
    (a) The CWI Clients are the direct holders of 19,425,906,043 Ordinary Shares, constituting approximately 18.0% of the outstanding Ordinary Shares. The foregoing percentage is calculated based on 108,050,720,920 Ordinary Shares that were expected to be issued and outstanding as of October 13, 2023, as reported by the Issuer in its Form 6-K, filed with the SEC on October 13, 2023.
           
    (b) See rows (7) through (10) of the cover page to this Schedule 13D, which are incorporated herein by reference.
           
    (c) Except as set forth in Item 3, the CWI Clients have not engaged in any transactions in Ordinary Shares during the past sixty days.
           
    (d)

    Except for the CWI Clients which are the direct holders of Ordinary Shares, no other person is known by the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any Ordinary Shares that may be beneficially owned by the Reporting Person.

     

    Two of the CWI Clients are the direct holders of more than five percent of the Ordinary Shares. American High-Income Trust, a Delaware statutory trust, received 9,474,891,765 Ordinary Shares pursuant to the Plan. The Income Fund of America, a Delaware statutory trust, received 7,363,075,902 Ordinary Shares pursuant to the Plan.

           
    (e) Not applicable.    
           
    Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
     
     

    The responses set forth in Item 4 are incorporated herein by reference.

    Except as otherwise described in this Schedule 13D, there are no contracts, arrangements, understandings or relationships between the Reporting Person and any other person with respect to any securities of the Issuer.

     

    Item 7. Material to be Filed as Exhibits.    
         
      Exhibit 99.1 Shareholders’ Agreement, dated as of October 12, 2023, among Venator Materials PLC, the CWI Clients and the other shareholders party thereto.

     

     

     

     

    CUSIP No. G9329Z100

     

     

    13D

     

    Page 5 of 6

     

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    CAPITAL WORLD INVESTORS

     

    /s/ Erik A. Vayntrub

     

      Erik A. Vayntrub
      (Name)
     

     

    Senior Vice President and Senior Counsel, Fund Business Management Group, Capital Research and Management Company

      (Title)
     

     

    October 30, 2023

      (Date)

     

     

     

     

     

    CUSIP No. G9329Z100

     

     

    13D

     

    Page 6 of 6

     

     

    SCHEDULE A

    The name, present principal occupation, and citizenship of each investment committee member of Capital World Investors is set forth below. The business address of each person listed below is Capital World Investors, 333 South Hope Street, 55th Floor, Los Angeles, CA 90071.

     

    INVESTMENT COMMITTEE MEMBERS OF CAPITAL WORLD INVESTORS

    Name     Present Principal Occupation   Citizenship
    Paul R. Benjamin     Partner – Capital World Investors   United States
    Alan N. Berro     Partner – Capital World Investors   United States
    Michael Cohen     Partner – Capital World Investors   United Kingdom
    Tomoko N. Fortune     Partner – Capital World Investors   United States
    Leo K. Hee     Partner – Capital World Investors   Malaysia
    Jin K. Lee     Partner – Capital World Investors   United States
    Lara Pellini     Partner – Capital World Investors   Italy
    Anne-Marie Peterson     Partner – Capital World Investors   United States
    Andraz Razen     Partner – Capital World Investors   Slovenia
    Erik A. Vayntrub     Senior Vice President and Senior Counsel, Fund Business Management Group, Capital Research and Management Company   United States
    Diana Wagner     Partner – Capital World Investors   United States
    Alan J. Wilson     Partner – Capital World Investors   United States
               
               
               
               
               
               
               

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $VNTR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VNTR

    DatePrice TargetRatingAnalyst
    10/6/2022$2.04 → $0.65Neutral → Sell
    UBS
    9/19/2022$2.00 → $0.60Market Perform → Underperform
    BMO Capital Markets
    3/22/2022$2.50 → $2.00Neutral → Underperform
    BofA Securities
    2/23/2022$4.50 → $3.00Buy
    Deutsche Bank
    1/4/2022$3.50 → $2.95Neutral
    UBS
    8/16/2021$5.50 → $4.50Buy
    Deutsche Bank
    8/5/2021$3.50Buy → Neutral
    B of A Securities
    More analyst ratings

    $VNTR
    SEC Filings

    See more
    • SEC Form 15-12G filed by Venator Materials PLC

      15-12G - Venator Materials PLC (0001705682) (Filer)

      2/13/24 4:30:26 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form EFFECT filed by Venator Materials PLC

      EFFECT - Venator Materials PLC (0001705682) (Filer)

      2/12/24 12:15:06 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Venator Materials PLC

      S-8 POS - Venator Materials PLC (0001705682) (Filer)

      2/2/24 4:35:06 PM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Financials

    Live finance-specific insights

    See more
    • Venator Announces Fourth Quarter and Full-Year 2022 Results, Strategic Review Underway Against Challenging Macroeconomic Backdrop

      WYNYARD, UK, Feb. 21, 2023 /PRNewswire/ --  Fourth Quarter 2022 and Other Highlights The macro-economic environment deteriorated sharply in the second half of 2022 leading to significantly lower product demand and higher raw material and energy costs, with TiO2 sales volumes (44)% lower compared to the fourth quarter 2021 and (28)% lower compared to the prior periodNet loss attributable to Venator of $(228) million compared to net income of $14 million in the prior year periodAdjusted EBITDA of $(57) million compared to $40 million in the prior year periodNet cash used in operating activities was $(27) million and free cash flow was $(48) millionDiluted loss per share of $(2.11) and adjusted

      2/21/23 6:00:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator to Discuss Fourth Quarter and Full Year 2022 Results on February 21, 2023

      WYNYARD, UK, Feb. 9, 2023 /PRNewswire/ -- Venator Materials PLC (NYSE:VNTR) ("Venator") will hold a conference call to discuss its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023, at 08:00 a.m. ET. Results will be released to the public before the market opens that day via PR Newswire. Call-in numbers for the conference call: U.S. participants 1-833-366-1118 International participants 1-412-902-6770 (No passcode required) In order to facilitate the registration process, you may use the following link to pre-register for the conference call. Callers who pre-register will be given a unique PIN and separate call-in number to gain immediate access to the call an

      2/9/23 6:00:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Strategic Review Update, Appointment of Advisors, Two New Independent Directors and Chairman, Engagement with Stakeholders

      Fourth Quarter 2022 Highlights Macro environment continues to be challenging due to significantly higher energy costs and lower product demandAdjusted EBITDA for the fourth quarter of 2022 estimated to be negative $(57)-(62) millionLiquidity position is estimated at approximately $275 million as of December 31, 2022Moelis & Company and Kirkland & Ellis appointed as respective financial and legal advisors, in addition to Alvarez & Marsal as the previously engaged operational advisor, to assist with strategic review and engagement with stakeholdersAppointment of two new independent directors, Stefan M. Selig and Jame Donath, who bring extensive and highly relevant experience to the BoardStefan

      1/20/23 6:45:00 AM ET
      $SAFE
      $SPG
      $VNTR
      Real Estate Investment Trusts
      Real Estate
      Major Chemicals
      Industrials

    $VNTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Venator Materials PLC

      SC 13G - Venator Materials PLC (0001705682) (Subject)

      2/14/24 2:47:34 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form SC 13D filed by Venator Materials PLC

      SC 13D - Venator Materials PLC (0001705682) (Subject)

      12/4/23 5:09:58 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form SC 13D filed by Venator Materials PLC

      SC 13D - Venator Materials PLC (0001705682) (Subject)

      12/4/23 5:09:15 PM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $VNTR
    Leadership Updates

    Live Leadership Updates

    See more
    • SEC Form 4: van de Kerkhof Heike disposed of $47,152 worth of Ordinary Share (11,417 units at $4.13) and was granted 29,056 units of Ordinary Share to satisfy tax liability (Amendment)

      4/A - Venator Materials PLC (0001705682) (Issuer)

      4/28/21 3:34:44 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form 4: Huntsman Peter R was granted 29,056 units of Ordinary Share and disposed of $25,267 worth of Ordinary Share (6,118 units at $4.13), increasing direct ownership by 229% to 32,938 units to cover taxes (Amendment)

      4/A - Venator Materials PLC (0001705682) (Issuer)

      4/28/21 3:34:09 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form 4: Lakshman Vir was granted 29,056 units of Ordinary Share and disposed of $46,871 worth of Ordinary Share (11,349 units at $4.13) (tax liability) (Amendment)

      4/A - Venator Materials PLC (0001705682) (Issuer)

      4/28/21 3:35:28 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Announces Changes to Board of Directors

      WYNYARD, UK, Aug. 9, 2022 /PRNewswire/ -- Venator Materials PLC (NYSE:VNTR) ("Venator") today announced the resignation of Kathy Patrick from its Board of Directors and the appointment of Miguel Kohlmann to its Board of Directors, both effective August 9, 2022. Ms. Patrick has served as a director since the Company's IPO in 2017 and served on Venator's Audit Committee and Compensation Committee at the time of her resignation. She is resigning due to other professional commitments. Mr. Kohlmann is based in Europe and has substantial industry experience as a former CEO and via service on a number of boards, including the listed Danish building materials group H+H.  Mr. Kohlmann is an independe

      8/9/22 4:15:00 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Board Appoints New Director

      WYNYARD, UK, Feb. 11, 2021 /PRNewswire/ -- Venator Materials PLC (NYSE: VNTR) ("Venator") announced today that Vir Lakshman has been appointed to serve as a member of its Board of Directors. The appointment of Vir Lakshman was effective February 11, 2021. Mr. Lakshman worked for KPMG in Germany from 1999 to July 2019, where he was Head of Chemicals and Life Sciences in Germany and a Deal Advisory Partner. Prior to KPMG Mr. Lakshman held senior positions at GE Capital, including that of CFO at Budapest Bank in Hungary, and worked for Coopers and Lybrand (now PwC) in the UK and Germany. Mr. Lakshman, a UK Chartered Accountant, was appointed to serve as Chair of the Audit Committee. Simon Tu

      2/11/21 4:30:00 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Board Elects Three New Directors

      WYNYARD, UK, Jan. 4, 2021 /PRNewswire/ -- Venator Materials PLC (NYSE: VNTR) ("Venator") announced today that Barry B. Siadat, Aaron C. Davenport and Heike van de Kerkhof have been elected as new members to its Board of Directors. The appointment of Dr. Siadat was effective December 31, 2020. Prior to co-founding SK Capital Partners, Dr. Siadat worked for 37 years in the chemicals and materials industries as an inventor, operator and investor. Dr. Siadat has been the chairman of several specialty materials and chemicals companies. He currently serves as Chairman of the Board for Ascend Performance Materials, Aristech Acrylics, Archroma and SI Group. Additionally, he serves on the Board o

      1/4/21 6:59:00 AM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Venator Materials downgraded by UBS with a new price target

      UBS downgraded Venator Materials from Neutral to Sell and set a new price target of $0.65 from $2.05 previously

      10/6/22 7:35:46 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Materials downgraded by BMO Capital Markets with a new price target

      BMO Capital Markets downgraded Venator Materials from Market Perform to Underperform and set a new price target of $0.60 from $2.00 previously

      9/19/22 7:38:07 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Materials downgraded by BofA Securities with a new price target

      BofA Securities downgraded Venator Materials from Neutral to Underperform and set a new price target of $2.00 from $2.50 previously

      3/22/22 7:20:16 AM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Venator Reaches Comprehensive Agreement to Enter Prepackaged Chapter 11 to Significantly Reduce Debt and Promptly Emerge Positioned for Long-Term Growth

      WYNYARD, UK, May 15, 2023 /PRNewswire/ -- Venator Materials PLC ("Venator" or the "Company") (NYSE:VNTR), a global manufacturer and marketer of chemical products, announces that it has reached an agreement with the overwhelming majority of its lenders and noteholders on the terms of a comprehensive recapitalization plan. The agreement will equitize nearly all of the Company's funded debt, strengthen its balance sheet and facilitate an infusion of new capital, which will position the Company for future growth and success.   The recapitalization will be implemented through a prepackaged Chapter 11 process in the United States and will be financed by a debtor-in-possession ("DIP") financing fac

      5/15/23 6:00:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Completes Divestiture of Iron Oxide Business

      WYNYARD, UK, April 3, 2023 /PRNewswire/ -- Venator Materials PLC ("Venator") (NYSE:VNTR) announced today that it has completed the sale of its Iron Oxide business to Cathay Industries. The enterprise value of the transaction was $140 million and Venator expects to receive cash proceeds of approximately $130 million net of working capital adjustments, taxes, fees and other closing cash adjustments. Venator expects an approximate $50 million reduction of its ABL facility resulting in a net liquidity improvement of approximately $80 million. About VenatorVenator is a global manufacturer and marketer of chemical products that comprise a broad range of pigments and additives that bring color and

      4/3/23 6:32:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Files Annual Report on Form 20-F

      WYNYARD, UK,  Feb. 23, 2023 /PRNewswire/ -- Venator Materials PLC ("Venator") (NYSE:VNTR) has filed its annual report on Form 20-F for the year ended December 31, 2022, with the U.S. Securities and Exchange Commission. The 2022 Form 20-F is available on Venator's website at https://www.venatorcorp.com/investor-relations and on the website of the U.S. Securities and Exchange Commission at www.sec.gov. Hard copies of the complete audited financial statements included in the 2022 Form 20-F are available to shareholders free of charge upon request. About VenatorVenator is a global manufacturer and marketer of chemical products that comprise a broad range of pigments and additives that bring colo

      2/23/23 4:15:00 PM ET
      $VNTR
      Major Chemicals
      Industrials